Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-015220
Filing Date
2026-05-06
Accepted
2026-05-06 16:38:22
Documents
65
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20260331_10q.htm   iXBRL 10-Q 727983
2 EXHIBIT 31.1 ex_951222.htm EX-31.1 22147
3 EXHIBIT 31.2 ex_951223.htm EX-31.2 22222
4 EXHIBIT 32.1 ex_951224.htm EX-32.1 6656
5 EXHIBIT 32.2 ex_951225.htm EX-32.2 6702
11 a01.jpg GRAPHIC 45543
  Complete submission text file 0001437749-26-015220.txt   4476763

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20260331.xsd EX-101.SCH 43493
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20260331_def.xml EX-101.DEF 289627
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20260331_lab.xml EX-101.LAB 237049
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20260331_pre.xml EX-101.PRE 317443
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20260331_cal.xml EX-101.CAL 33558
69 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20260331_10q_htm.xml XML 569467
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 26949174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)